Skip to main content

BIO International Convention

16-19 June 2025 | Boston, Massachusetts ...

Cell & Gene Therapy Summit

7-9 July 2025 | Orlando, Florida ...

Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility

Touchlight Wins ISPE Facility of the Year Award for Innovation, Recognised for Revolutionary dbDNA™ Manufacturing at Morelands Facility Published: 12 ...

Cell & Gene Therapy World Asia 2025

10 - 11 September 2025 | Singapore, Asia ...

Cell & Gene Meeting on the Mesa

6 - 8 October 2025 | Phoenix, AZ ...

European Society of Gene and Cell Therapy (ESGCT)

7 - 10 October 2025 | Seville, Spain ...

CAR-TCR Boston Conference

23 - 26 September 2025 | Boston, Massachusetts ...

ASGCT

13-17 May 2025 | New Orleans, Lousiana ...

World Vaccine Congress

21 April 2025 | Washington DC ...

Cell & Gene Meeting on the Med

15 April 2025 | Rome, Italy ...

Advanced Therapies

18 March 2025 | London, UK ...

Precision Genome Engineering

3 March 2025 | Killarney, Ireland ...

CAR-TCR Europe Conference

25 February 2025 | London, UK ...

Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms

Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms Published: 27 January 2025 ...

Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health

Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health Published: 16 January 2025 ...

Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA

Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first ...

Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus

Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus Published: ...

Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing

Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing Published: 23 July 2024 ...

Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response

Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response Published: 2 July 2024 Touchlight to participate ...

Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template.

Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template. Published: 9 ...

Touchlight awarded grant extension to further develop DNA-enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory

Touchlight awarded grant extension to further develop DNA-enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & ...

University of Liverpool to use Touchlight’s rapid enzymatic dbDNA in fully personalised neoantigen cancer vaccine clinical study

University of Liverpool to use Touchlight’s rapid enzymatic dbDNA in fully personalised neoantigen cancer vaccine clinical study Published: 4 April ...

Touchlight awarded tender to supply enzymatic dbDNA to CPI’s RNA Centre of Excellence

Touchlight awarded tender to supply enzymatic dbDNA to CPI’s RNA Centre of Excellence Published: 28 March 2024 Touchlight, an innovation-driven ...

Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study

Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb’s VMB-100 for first-in-human clinical study Published: 21 November 2023 Based ...

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA Published: 24 July 2023 Curia collaborates with Touchlight to expand ...

20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project

20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project Published: 18 April 2023 Curia collaborates with Touchlight ...

Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing

Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing Published: 29 March 2023 headline Hampton, UK, ...

Touchlight announces first FDA clearance of an IND utilising doggybone DNA

Touchlight announces first FDA clearance of an IND utilising doggybone DNA Published: 28 February 2023 Enzymatic doggybone DNA material used ...

Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform

Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform Published: 15 November ...

Lonza and Touchlight collaborate on end-to-end mRNA offering

Lonza and Touchlight collaborate on end-to-end mRNA offering Published: 6 September 2022 Collaboration expands Lonza’s end-to-end offering for mRNA manufacturing ...

Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and gene therapies

Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and ...

AskBio and Touchlight Restructure Joint Venture

AskBio and Touchlight Restructure Joint Venture Published: 8 February 2022 Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned ...

Plasmid DNA Challenges In Advanced Therapy Manufacturing

Plasmid DNA Challenges In Advanced Therapy Manufacturing Published: 24 November 2021 Dr Tommy Duncan Introducing doggybone DNA, a synthetic antibiotic-free ...

Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50

Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50 Published: 22 ...

Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand

Touchlight raises £42 million ($58 million) to meet unprecedented global DNA demand Published: 11 March 2021 Touchlight raises £42 million ...

Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services

Touchlight appoints Karen Fallen as CEO of Touchlight DNA Services Published: 15 October 2020 Former Lonza President of Biologics Manufacturing ...

Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture

Touchlight Genetics and Stonehaven Incubate form Touchlight Aquaculture Published: 29 September 2020 Curia collaborates with Touchlight to expand its mRNA ...